A Novel Technique Using Proline Mesh for Simultaneous Excision and Soft Tissue Suspension in the Management of Craniofacial Neurofibromatosis Type 1

Jett K. and Friedman J.M.: Clinical and genetic aspects
of neurofibromatosis 1. Genet Med., 12: 1-11, 2010.
2- Todman D.: Warts and the kings of Parthia: An ancient
representation of hereditary neurofibromatosis depicted
in coins. J. Hist. Neurosci., 17 (2): 141-146, 2008.
3- Friedrich R.E., Giese M., Schmelzle R., Mautner V.F. and
Scheuer H.A.: Jaw malformations plus displacement and
numerical aberrations of teeth in neurofibromatosis type
1: A descriptive analysis of 48 patients based on panoramic
radiographs and oral findings. J. Craniomaxillofac. Surg.,
31 (1): 1-9, 2003.
4- Chrcanovic B.R., Gomez R.S. and Freire-Maia B.: Neurofibromatosis
type 1 associated with bilateral central
giant cell granuloma of the mandible. J. Craniomaxillofac.
Surg., 39 (7): 538-543, 2011.
5- Friedrich R.E., Hagel C. and Scheurer H.A.: Orbital
dysplasia and plexiform neurofibroma in NF1. J. Craniomaxillofac.
Surg., 36: S152, 2008.
6- Apaydin A. and Chan T.: Oral manifestations of neurofibromatosis
1: A case report. J. Craniomaxillofac. Surg.,
36: S221, 2008.
7- Koblin I. and Reil B.: Changes of the facial skeleton in
cases of neurofibromatosis. J. Maxillofac. Surg., 3 (1):
23-27, 1975.
8- Krastinova-Lolov D. and Hamza F.: The surgical management
of cranio-orbital neurofibromatosis. Ann. Plast.
Surg., 36 (3): 263-269, 1996.
9- Jackson I.T.: Management of craniofacial neurofibromatosis.
Facial Plast. Surg. Clin. North Am., 9 (1): 59-75,
2001.
10- van der Meulen J.: Orbital neurofibromatosis. Clin. Plast.
Surg., 14 (1): 123-135, 1987.
11- Chou E-K., Chen K-T. and Tansipek B.: Palliative surgical
treatment of the plexiform facialneurofibroma e a case
report. J. Plast. Surg. Assoc. R.O.C., 14: 249-255, 2015.
12- Merker V.L., Bredella M.A., Cai W., et al.: Relationship
between whole-body tumor burden, clinical phenotype,
and quality of life in patients with neurofibromatosis.
Am. J. Med. Genet A., 164A: 1431-1437, 2014.
13- Hirbe A.C. and Gutmann D.H.: Neurofibromatosis type
1: A multidisciplinary approach to care. Lancet Neurol.,
13: 834-843, 2014.
14- Parsons C.M., Canter R.J. and Khatri VP.: Surgical management
of neurofibromatosis. Surg. Oncol. Clin. N. Am.,
18: 175-196, 2009.
15- Marchac D.: Intracranial enlargement of the orbital cavity
and palpebral remodeling for orbitopalpebral neurofibromatosis.
Plast. Reconstr. Surg., 73: 534-543, 1984.
16- Jackson I.T.: Neurofibromatosis of the skull base. Clin.
Plast. Surg., 22: 513-530, 1995.
17- Jackson I.T., Carbonnel A., Potparic Z., et al.: Orbitotemporal
neurofibromatosis: Classification and treatment.
Plast. Reconstr. Surg., 92: 1-11, 1993.
18- Lee V., Ragge N.K. and Collin J.R.: Orbitotemporal
neurofibromatosis. Clinical features and surgical management.
Ophthalmology, 111: 382-388, 2004.
19- Marchac D. and Britto J.A.: Remodelling the upper eyelid
in the management of orbitopalpebral neurofibromatosis.
Br. J. Plast. Surg., 58: 944-956, 2005.
20- Erb M.H., Uzcategui N., See R.F. and Burnstine M.A.:
Orbitotemporal neurofibromatosis: classification and
treatment. Orbit., 26: 223-228, 2007.
21- Singhal D., Chen Y.C., Tsai Y.J., et al.: Craniofacial
neurofibromatosis: Treatment of the midface deformity.
J. Craniomaxillofac. Surg., 42: 595-600, 2014.
22- Fattahi T.T.: An overview of facial aesthetic units. J. Oral
Maxillofac. Surg., 61: 1207-1211, 2003.
23- Burget G.C. and Menick F.J.: The subunit principle in
nasal reconstruction. Plast. Reconstr. Surg., 76: 239-247,
1985.
24- Shuxian Z., Wanhua Z. and Bingheng L.: 3D reconstruction
of the structure of a residual limb for customising the
design of a prosthetic socket. Med. Eng. Phys., 27: 67-
74, 2005.
25- Liu Y., Gong Z., He L., et al.: Individual digital design
and functional reconstruction of large mandibular defect
with computer-aided design computer aided manufacture
technique. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi,
19: 803-806, 2005.
26- Li J., Zhang H., Yin P., et al.: A new measurement technique
of thecharacteristics of nutrient artery canals in tibias
using Materialise's Interactive Medical Image Control
System Software. Biomed Res. Int., 2015: 171672, 2015.
27- Gabbay J.S., Yuan J.T., Andrews B.T., et al.: Fibrous
dysplasia of the zygomaticomaxillary region: Outcomes
of surgical intervention. Plast. Reconstr. Surg., 131: 1329-
1338, 2013.
28- Singhal D., Chen Y.C., Chen Y.R., et al.: Soft tissue
management of orbitotemporal neurofibromatosis. J.
Craniofac. Surg., 24: 269-272, 2013.
29- Hivelin M., Wolkenstein P., Lepage C., et al.: Facial
aesthetic unit remodeling procedure for neurofibromatosis
type 1 hemifacial hypertrophy: report on 33 consecutive
adult patients. Plast Reconstr Surg., 125: 1197-1207,
2010. Surg. Oncol. Clin. N. Am., 18: 175-196, 2009.
30- Hivelin M., Wolkenstein P., Lepage C., et al.: Facial
aesthetic unit remodeling procedure for neurofibromatosis
type 1 hemifacial hypertrophy: Report on 33 consecutive
adult patients. Plast. Reconstr. Surg., 125: 1197-1207,
2010.
31- Nguyen R., Ibrahim C., Friedrich R.E., et al.; Growth
behavior of plexiform neurofibromas after surgery. Genet
Med., 15: 691-697, 2013.
32- Altan-Yaycioglu R. and Hintschich C.: Clinical features
and surgical management of orbitotemporal neurofibromatosis:
A retrospective interventional case series. Orbit.,
29: 232-238, 2010.
33- Nagata S.: A systematic multiple stage surgical approach
for attainment of satisfactory and favourable surgical
results in an extremely severe von Recklinghausen's
disease, elephantiasis neurofibromatosa. J. Plast. Reconstr.
Aesthet. Surg., 59: 662-674, 2006.
34- Bruwer A.J. and Kierland R.R.: Neurofibromatosis and
congenital unilateral pulsating and nonpulsating exophthalmos.
AMA Arch. Ophthalmol., 53: 2-12, 1955.
35- Hunt J.C. and Pugh D.G.: Skeletal lesions in neurofibromatosis.
Radiology, 76: 1-20, 1961.
36- Havlik R.J. and Boaz J.: Cranio-orbital-temporal neurofibromatosis:
Are we treating the whole problem? J. Craniofac.
Surg., 9: 529-535, 1998.
37- Hersh J.H.: Health supervision for children with neurofibromatosis.
Pediatrics, 121: 633-642, 2008.
38- Snyder B.J., Hanieh A., Trott J.A., et al.: Transcranial
correction of orbital neurofibromatosis. Plast. Reconstr.
Surg., 102: 633-642, 1998.
39- Greig A.V., Kirkpatrick N.A., Joshi N., et al.: Giant
hemifacial plexiform neurofibroma arising from trigeminal
ganglion. J. Craniofac. Surg., 20: 833-836, 2009.
40- Chen Y.R., Chen K.T. and Noordhoff M.S.: Facial elephantiasis
neurofibromatosa: Excision and skin graft. Ann.
Plast. Surg., 23: 547-551, 1989.
41- Phillips J.H., Gruss J.S., Wells M.D., et al.: Periosteal
suspension of the lower eyelid and cheek following
subciliary exposure of facial fractures. Plast. Reconstr.
Surg., 88: 145-148, 1991.
42- Gomez-Cia T., Sicilia-Castro D., Infante-Cossio P., et al.:
Second human facial allotransplantation to restore a severe
defect following radical resection of bilateral massive
plexiform neurofibromas. Plast. Reconstr. Surg., 127:
995-996, 2011.
43- Singhal D., Chen Y.C., Seselgyte R., Chen P.K. and Chen
Y.R.: Craniofacial neurofibromatosis and tissue expansion:
Long-term results. J. Plast. Reconstr. Aesthet. Surg., 65
(7): 956-959, 2012.
44- Singhal D., Chen Y.C., Fanzio P.M., Lin C.H., Chuang
D.C., Chen Y.R., et al.: Role of free flaps in the management
of craniofacial neurofibromatosis: Soft tissue coverage
and attempted facial reanimation. J. Oral Maxillofac.
Surg., 70 (12): 2916-2922, 2012.
45- Acartürk T.O., Yigenoglu B. and Pekedis O.: Excision
and “transcutaneous” lift in patients with neurofibromatosis
of the fronto-temporo-orbital and auricular regions. J.
Craniofac. Surg., 20: 771-774, 2009.
46- Xie Y., Li Q., Zheng D., et al.: Correction of hemifacial
atrophy with autologous fat transplantation. Ann. Plast.
Surg., 59: 645-653, 2007.
47- Chaudhry I.A., Morales J., Shamsi F.A., et al.: Orbitofacial
neurofibromatosis: Clinical characteristics and treatment
outcome. Eye (Lond), 26: 583-592, 2012